Tessera Therapeutics Presents New Preclinical Data Highlighting Advancements Across Its Portfolio Programs and Platforms at the American Society of Gene and Cell Therapy 27th Annual Meeting
May 10, 2024 06:00 ET
|
Tessera Therapeutics
Gene Writing™ platform demonstrates highly efficient in vivo correction of mutation responsible for alpha-1 antitrypsin deficiency (AATD) to wild-typeCombination of proprietary lipid nanoparticle...
Professional Services Marketing, Sales and AI Expert to Drive Innovation and Growth for Chief Outsiders Clients
May 09, 2024 09:00 ET
|
Chief Outsiders
AIKEN, SC, May 09, 2024 (GLOBE NEWSWIRE) -- Dr. Carl Henson, a seasoned executive with an AI-focused doctorate and a proven track record in revitalizing sales and marketing landscapes, will now...
Wave Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update
May 09, 2024 07:30 ET
|
Wave Life Sciences USA, Inc.
RestorAATion-2 clinical trial of WVE-006 in AATD patients underway; expected proof-of-mechanism data in patients with AATD remains on track for 2024 INHBE program for obesity expected...
VPN Risk Report Finds More Than Half of Organizations Experienced a VPN-related Cyberattack in the Last Year
May 07, 2024 08:00 ET
|
Zscaler, Inc.
VPN security concerns rise as 91% of respondents express concerns about VPNs leading to a compromising breachThe survey identifies the top threats exploiting VPN vulnerabilities to be ransomware...
Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at the ARVO Annual Meeting
May 06, 2024 08:00 ET
|
Belite Bio, Inc
Additional analysis of visual acuity loss, genotypic profiles, and retinal imaging data from a 24-month Phase 2 trial of Tinlarebant in adolescent Stargardt disease patients provides further support...
CISO Leadership: Making GenAI Initiatives Safe and Secure will Pepper the Discussion at HMG Strategy’s 8th Annual New York CISO & Technology Leadership Summit on June 11
May 03, 2024 10:29 ET
|
HMG Strategy
WESTPORT, Conn., May 03, 2024 (GLOBE NEWSWIRE) -- HMG Strategy, the World’s #1 platform for enabling technology executives to reimagine the enterprise and reshape the business world, is excited to...
Monte Rosa Therapeutics Announces the Departure of Owen Wallace, Ph.D., Chief Scientific Officer
May 02, 2024 16:01 ET
|
Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics Announces the Departure of Owen Wallace, Ph.D.,
Chief Scientific Officer
Vicinitas Therapeutics Appoints Adam Hughes as Chief Scientific Officer
May 02, 2024 08:00 ET
|
Vicinitas Therapeutics
SOUTH SAN FRANCISCO, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Vicinitas Therapeutics, a biotechnology company advancing a proprietary targeted protein stabilization platform to develop novel...
BridgeBio Pharma Reports First Quarter 2024 Financial Results and Business Update
May 02, 2024 07:30 ET
|
BridgeBio Pharma, Inc.
- Presented cardiac magnetic resonance (CMR) imaging evidence consistent with clinical improvement observed in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) in the ATTRibute-CM Phase 3...
Ocugen Announces CSO to Present on Modifier Gene Therapy at Retina World Congress
May 02, 2024 07:15 ET
|
Ocugen
MALVERN, Pa., May 02, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...